853400-76-7 Usage
Description
L-Glutamic acid, glycyl-2-methyl-L-prolylis a chemical compound that combines L-glutamic acid, an essential amino acid with key roles in the human nervous system and as a flavor enhancer in the food industry, with glycyl-2-methyl-L-prolyl-, a dipeptide consisting of two amino acids. This unique combination may offer potential applications in medicine, biotechnology, and food science.
Uses
Used in Pharmaceutical Industry:
L-Glutamic acid, glycyl-2-methyl-L-prolylis used as a building block for peptides and proteins for the development of pharmaceuticals, leveraging its dipeptide structure to create novel therapeutic agents.
Used in Biotechnology:
L-Glutamic acid, glycyl-2-methyl-L-prolylis used as a component in biotechnological applications, potentially contributing to the advancement of peptide-based therapies and diagnostic tools.
Used in Food Science:
L-Glutamic acid, glycyl-2-methyl-L-prolylis used as a flavor enhancer in the food industry, capitalizing on the taste-modifying properties of L-glutamic acid to improve the overall flavor profile of various food products.
Check Digit Verification of cas no
The CAS Registry Mumber 853400-76-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,3,4,0 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 853400-76:
(8*8)+(7*5)+(6*3)+(5*4)+(4*0)+(3*0)+(2*7)+(1*6)=157
157 % 10 = 7
So 853400-76-7 is a valid CAS Registry Number.
853400-76-7Relevant articles and documents
COMPOSITIONS OF TROFINETIDE
-
, (2021/02/12)
This disclosure describes compounds of Formula (I), stereoisomers, side compounds thereof, pharmaceutical compositions and methods of manufacturing such compounds, using silylation reagents and producing compositions and products made using such methods. More particularly, this disclosure describes manufacture of trofinetide and side products, compositions and products containing such compounds, for pharmaceutical uses to treat neurodegenerative or neurodevelopmental disorders.
TREATMENT OF AUTISM SPECTRUM DISORDERES USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID
-
Page/Page column 29; 32, (2012/08/08)
This invention provides compounds, compositions and methods for treating Autism Spectrum Disorders (ASD) using glycyl-2-methylprolyl-glutamic acid (G-2-MePE) and analogs thereof. Autism Spectrum Disorders include Autism, Autistic Disorder, Asperger Syndro
Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): Synthesis and structure-activity relationships
Alonso De Diego, Sergio A.,Munoz, Pilar,Gonzalez-Muniz, Rosario,Herranz, Rosario,Martin-Martinez, Mercedes,Cenarruzabeitia, Edurne,Frechilla, Diana,Del Rio, Joaquin,Jimeno, M. Luisa,Garcia-Lopez, M. Teresa
, p. 2279 - 2283 (2007/10/03)
A series of GPE analogues, including modifications at the Pro and/or Glu residues, was prepared and evaluated for their NMDA binding and neuroprotective effects. Main results suggest that the pyrrolidine ring puckering of the Pro residue plays a key role
